CompoAtlas

Myrtillier Macérat de jeunes pousses Bio

Food supplement declared in France, declaration No 2023-4-582, decision dated 14 April 2023

Myrtillier Macérat de jeunes pousses Bio, from LABORATOIRES MESSEGUE, is a food supplement declared in France. Status: declared in France, may be marketed. Main ingredients: Vaccinium myrtillus 22.5 mg per day. None of the rules we check flags an issue with its declared composition.

Brand
not provided
Food business operator placing the product on the market
LABORATOIRES MESSEGUE
Status
Declared in France, may be marketed: the authorities did not object to the declaration (this is neither an authorisation nor a safety assessment)
Form
Dropper
Daily dose
15 gouttes (soit 0,42 ml)
Directions for use
Prendre pendant 3 semaines, 5 à 15 gouttes (pures ou diluées dans un verre d'eau) le matin à jeun
Not recommended (according to the manufacturer)
Breastfeeding women, Children (under 12), Young children (aged 1 to 3), Pregnant women, Infants (under 1 year), Children (under 6), Children (under 10)

Declaration 242694, procedure Article 15. Compl'Alim, food supplement declarations (France), retrieved 15 November 2026.

Declared composition

Plants

PlantPartPreparationPer day
Vaccinium myrtillus L.Jeune pousseAutre macérât22.5 mg

Additives

E422

Other ingredients

Alcool, eau

List from the declaration, administrative decision dated (Compl'Alim, food supplement declarations (France)).

Photograph the packaging

Label warnings

Une consommation excessive peut avoir des effets laxatifs.Ne convient pas aux enfants, femmes enceintes ou allaitantes.

Regulatory points

None of the rules we check applies to the declared ingredients.

This information reproduces the manufacturer's declaration to the administration (DGAL). It does not say whether the product is effective and does not replace advice from a doctor or pharmacist, particularly during pregnancy or when taking medication.

Official warnings (Health Canada)

Health Canada publishes warnings on these ingredients:

  • Vaccinium myrtillus L.
    Read the warning, when it applies and the studies cited

    BILBERRY - VACCINIUM MYRTILLUS - Buccal

    Route of administration: Buccal (Blumenthal et al. 2000)

    Cautions and warnings

    Ask a health care practitioner/health care provider/health care professional/doctor/physician if symptoms persist or worsen.

    Health Canada monograph dated 30 January 2026

    BILBERRY - VACCINIUM MYRTILLUS - Oral

    Route of administration: Oral (Blumenthal et al. 2000)

    Cautions and warnings

    Condition of application: Relief of diarrhea.

    Ask a health care practitioner/health care provider/health care professional/doctor/physician if symptoms persist or worsen.

    Condition of application: Slowing the progression of disorders of the eye and to relieve symptoms related to non-complicated CVI.

    Ask a health care practitioner/health care provider/health care professional/doctor/physician if symptoms worsen.

    Health Canada monograph dated 25 October 2024

They concern the ingredient, not this product or its dose. They do not replace medical advice.

Is something on this product wrong or out of date, whether you are a reader or the brand? Write to contact@compoatlas.com: every correction is published in the corrections log.

Cite this page: CompoAtlas, “Myrtillier Macérat de jeunes pousses Bio: composition and regulation”, https://compoatlas.com/en/supplements/products/242694-myrtillier-macerat-de-jeunes-pousses-bio, updated 15 November 2026.

List recorded in 2023. Photograph the packaging to check whether it has changed.

Enter to analyse, Shift+Enter for a new line